author-photo

Emilia Quattrocchi

GlaxoSmithKline

4

Papers

153

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

A randomized, placebo-controlled experimental medicine study of RIPK1 inhibitor GSK2982772 in patients with moderate to severe rheumatoid arthritis.

2021 Arthritis Research & Therapy
Show All
- Source
- Cite
- Save
Citations (7)
Safety of Repeated Open-Label Treatment Courses of Intravenous Ofatumumab, a Human Anti-CD20 Monoclonal Antibody, in Rheumatoid Arthritis: Results from Three Clinical Trials.

2016 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (14)
Ofatumumab, a fully human anti-CD20 monoclonal antibody, in biological-naive, rheumatoid arthritis patients with an inadequate response to methotrexate: a randomised, double-blind, placebo-controlled clinical trial

2011 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (101)